identif
host
factor
need
zair
ebolaviru
ebov
entri
provid
insight
mechan
filoviru
uptak
factor
may
serv
potenti
antivir
target
order
identifi
novel
host
gene
pathway
involv
ebov
entri
gene
array
find
nation
cancer
institut
panel
human
tumor
cell
line
correl
permiss
ebov
glycoprotein
gp
mediat
entri
found
gene
encod
subunit
ampactiv
protein
kinas
ampk
strongli
correl
ebov
transduct
tumor
panel
ampk
inhibitor
compound
c
inhibit
infecti
ebov
replic
vero
cell
diminish
ebov
gpdepend
lassa
fever
viru
gpcdepend
entri
varieti
cell
line
dosedepend
manner
compound
c
also
prevent
ebov
gpmediat
infect
primari
human
macrophag
major
target
filovir
replic
vivo
consist
role
ampk
filoviru
entri
timeofaddit
studi
demonstr
compound
c
abrog
infect
ad
earli
time
point
becam
progress
less
effect
ad
later
compound
c
prevent
ebov
pseudovirion
intern
cellbound
particl
remain
suscept
trypsin
digest
presenc
inhibitor
absenc
mous
embryon
fibroblast
lack
catalyt
subunit
significantli
less
permiss
ebov
gpmediat
infect
wildtyp
counterpart
like
due
decreas
macropinocyt
uptak
total
find
implic
ampk
macropinocyt
event
need
ebov
gpdepend
entri
identifi
novel
cellular
target
new
filovir
antivir
f
ilovirus
envelop
virus
contain
neg
sens
nonseg
rna
genom
viru
famili
compos
two
genera
ebolaviru
marburgviru
viral
glycoprotein
gp
present
surfac
virion
compos
heterotrimer
complex
consist
interact
attach
factor
receptor
mediat
fusion
host
viral
membran
sever
cellular
adher
factorsreceptor
identifi
mediat
filoviru
intern
includ
epitheli
cell
sever
ctype
lectin
antigenpres
cell
upon
intern
ebolaviru
progress
endocyt
compart
lowphdepend
proteolyt
process
heavili
glycosyl
gp
cathepsin
b
l
cat
bl
gener
form
process
gp
interact
niemannpick
late
endosom
lysosom
compart
subsequ
event
poorli
defin
result
membran
fusion
rout
endocyt
uptak
filovirus
remain
controversi
caveolinmedi
endocytosi
clathrinmedi
endocytosi
macropinocytosi
implic
zair
ebolaviru
ebov
entri
strong
evid
support
role
macropinocytosi
varieti
cell
type
virionassoci
ebov
gp
interact
host
cell
stimul
actin
polymer
event
lead
membran
bleb
lamellipodium
format
macropinocytosi
result
viru
uptak
addit
actin
polymer
varieti
cell
signal
molecul
includ
rhoc
phosphatidylinositol
protein
kinas
c
pkc
axl
implic
macropinocyt
uptak
ebov
variou
cell
ampactiv
protein
kinas
ampk
regul
metabol
respond
level
amp
present
cell
recent
review
see
refer
surprisingli
critic
sensor
metabol
also
implic
regul
replic
virus
two
regulatori
subunit
well
catalyt
subunit
make
heterotrimer
ampk
complex
conserv
eukaryot
speci
anabol
process
cell
hydrolyz
atp
adp
amp
anabol
byproduct
accumul
amp
bind
subunit
ampk
caus
structur
chang
subsequ
phosphoryl
catalyt
subunit
requir
ampk
activ
amp
adp
bind
also
prevent
dephosphoryl
alpha
subunit
subsequ
inactiv
ampk
complex
cellular
phosphatas
ca
calmodulindepend
protein
kinas
kinas
camkk
phosphoryl
activ
ampk
undoubtedli
upstream
kinas
gener
ampk
activ
caus
cellular
switch
atpconsum
atpproduc
pathway
fatti
acid
oxid
glycolysi
glucos
uptak
addit
role
regul
metabol
recent
studi
implic
ampk
activ
actin
polymer
induct
macropinocytosi
phagocytosi
instanc
macrophag
diabet
mice
reduc
macropinocytosi
leptinenhanc
ampk
activ
increas
macropinocytosi
anoth
recent
studi
implic
mediat
ampkdepend
phagocytosi
moser
et
al
extend
work
investig
viru
intern
use
rna
interfer
rnai
screen
drosophila
kinom
identifi
import
ampk
activ
vaccinia
viru
vv
uptak
via
macropinocytosi
howev
pathway
activ
ampk
lead
actindepend
macropinocytosi
remain
poorli
defin
recent
appreci
import
macropinocytosi
filoviru
infect
sought
determin
ampk
involv
ebov
entri
studi
demonstr
ampk
requir
effici
ebov
entri
recognit
import
critic
cellular
kinas
ebov
infect
open
new
avenu
develop
filoviru
antivir
cell
cell
line
hela
vero
cell
maintain
dulbecco
modifi
eagl
medium
dmem
gibcobrl
contain
fetal
bovin
serum
fb
penicillinstreptomycin
panel
tumor
line
purchas
nation
cancer
institut
nci
development
therapeut
program
dtp
panel
cell
includ
cell
maintain
rpmi
medium
gibcobrl
contain
fb
hyclon
penicillinstreptomycin
wildtyp
wt
ampkdefici
ampk
mous
embryon
fibroblast
mef
maintain
dmem
supplement
fb
penicillinstreptomycin
hepe
lglutam
cell
maintain
co
unless
otherwis
note
peripher
blood
mononuclear
cell
pbmc
isol
whole
human
blood
use
ficollhypaqu
per
manufactur
instruct
sigmaaldrich
monocytederiv
macrophag
mdm
isol
adher
gelatinco
flask
previous
describ
freshli
isol
mdm
plate
densiti
cellswel
format
allow
differenti
day
rpmi
medium
contain
fb
autolog
human
serum
granulocytemacrophag
colonystimul
factor
ngml
evalu
pharmacolog
inhibitor
ampk
inhibitor
compound
c
also
known
dorsomorphin
phenyl
pyrimidin
nethylnisopropyl
amilorid
eipa
obtain
sigmaaldrich
smallmolecul
inhibitor
incub
concentr
note
figur
legend
cell
h
prior
viral
transduct
infect
time
note
experi
cell
transduc
rang
ebov
gppseudotyp
vesicular
stomat
virusenhanc
green
fluoresc
protein
vsvegfp
multipl
infect
moi
presenc
inhibitor
concentr
note
experi
four
hour
follow
transduct
medium
remov
replac
fresh
medium
contain
inhibitor
product
recombin
vsv
recombin
replicationcompet
vsv
express
mucin
domaindelet
zair
ebov
gp
ebov
gprvsv
produc
previous
describ
briefli
ebov
glycoprotein
delet
mucin
domain
ebov
gp
clone
genom
recombin
vsv
indiana
recombin
genom
contain
egfp
gene
place
vsvg
ebov
gp
clone
front
egfp
infecti
viru
gener
describ
previous
titer
determin
mucin
domaindelet
ebov
gp
use
extens
studi
previou
work
shown
glycoprotein
similar
tropism
fulllength
ebov
gp
higher
pseudovirion
titer
product
infecti
ebov
work
replicationcompet
ebov
perform
recombin
zair
ebov
encod
gfp
viru
origin
suppli
john
towner
cdc
atlanta
ga
viru
stock
produc
infect
vero
cell
moi
cultiv
day
time
cell
fluoresc
indic
complet
spread
viru
cultur
supernat
collect
cell
debri
pellet
centrifug
g
supernat
collect
overlaid
onto
sucros
cushion
sucros
wtvol
mm
hepe
ph
viru
pellet
ultracentrifug
g
h
supernat
remov
pellet
rins
phosphatebuff
salin
pb
viru
pellet
resuspend
pb
aliquot
frozen
product
vsv
pseudovirion
vsv
pseudovirion
produc
previous
describ
briefli
virion
bear
mucin
domaindelet
ebov
gp
vsv
g
lassa
fever
viru
lfv
gpc
produc
hek
cell
transfect
glycoproteinexpress
plasmid
follow
h
later
virion
transduct
newli
pseudotyp
virion
collect
h
supernat
filter
filter
viral
transduct
determin
h
later
analyz
egfp
express
use
flow
cytometri
vv
product
hela
cell
infect
vaccinia
viru
vv
western
reserv
strain
express
egfp
incub
day
infect
cell
popul
collect
pellet
subject
freez
thaw
releas
intracellular
virion
supernat
collect
frozen
use
determin
titer
stock
serial
dilut
viru
ad
vero
cell
quantifi
egfp
express
h
follow
infect
ebov
transduct
infect
studi
cga
screen
detail
compar
genom
analysi
cga
screen
previous
describ
briefli
cell
cell
line
transduc
equival
quantiti
pseudotyp
either
vsvg
ebov
gp
viral
transduct
effici
assess
h
posttransduct
flow
cytometrybas
analysi
egfp
express
averag
percentag
egfpexpress
cell
three
independ
assay
use
seed
file
compar
analysi
perform
http
dtpncinihgovcompar
statist
analysi
correl
find
perform
use
sa
softwar
packag
sa
institut
cellular
gene
correl
vsvgand
ebov
gpdepend
transduct
elimin
analysi
focus
studi
cellular
gene
correl
ebov
gpdepend
entri
ii
pseudovirion
transduct
studi
compound
c
present
first
h
transduct
equal
number
cell
incub
mucin
domaindelet
ebov
gpor
lfv
gpcpseudotyp
h
studi
use
moi
pseudovirion
wide
rang
moi
found
equival
sensit
compound
c
supernat
remov
replac
fresh
medium
contain
inhibitor
total
h
viral
transduct
determin
analyz
egfp
express
via
flow
cytometri
bd
facscalibur
studi
compound
c
remain
cell
durat
experi
equal
number
cell
incub
gp
presenc
compound
c
viral
transduct
determin
h
analyz
egfp
express
via
flow
cytometri
iii
ebov
gprvsv
infect
equal
number
cell
incub
dilut
seri
either
wt
vsv
vaccinia
viru
vv
vsv
nativ
glycoprotein
replac
ebov
glycoprotein
encod
egfp
report
gene
h
supernat
remov
replac
fresh
medium
cell
incub
h
lift
trypsin
fix
formaldehyd
infect
analyz
egfp
express
either
immunofluoresc
microscopi
flow
cytometri
iv
ebov
infect
cell
grown
confluenc
treat
h
compound
c
dimethyl
sulfoxid
dmso
dmso
alon
indic
fig
cell
infect
addit
recombin
zair
ebov
encod
egfp
moi
h
cell
imag
epifluoresc
microscop
fluoresc
cell
count
imag
use
cell
profil
softwar
broad
institut
use
custom
algorithm
avail
upon
request
work
ebov
perform
biosafeti
level
texa
biomed
research
institut
san
antonio
tx
confoc
microscopi
vero
cell
grown
polyllysineco
coverslip
incub
h
presenc
absenc
compound
c
incub
moi
equival
concentr
contain
glycoprotein
env
min
supernat
aspir
replac
prewarm
dmem
without
compound
c
viru
allow
intern
min
coverslip
fix
paraformaldehyd
previous
describ
cell
permeabil
triton
min
room
temperatur
actin
visual
stain
alexa
fluor
invitrogen
min
room
temperatur
microscopi
perform
nikon
confoc
microscop
zseri
slice
encompass
entir
cellular
field
oil
immers
obtain
total
phalloidin
signal
number
voxel
complet
zseri
determin
use
imari
version
softwar
bitplan
scientif
softwar
number
voxel
detect
divid
total
number
cell
within
analyz
zstack
gener
number
voxelscel
dextran
uptak
studi
vero
cell
wildtyp
ampk
mef
seed
format
vero
cell
pretreat
compound
c
eipa
h
indic
legend
fig
cell
incub
dextran
gml
conjug
fluorescein
invitrogen
h
presenc
absenc
drug
extracellular
dextran
remov
pb
wash
dextran
uptak
assay
intens
mean
fluoresc
intens
mfi
via
flow
cytometri
intern
assay
vero
cell
plate
format
cell
preincub
eipa
compound
c
h
cool
cell
incub
pseudovirion
addit
hour
baselin
valu
time
zero
medium
remov
cell
incub
two
incub
trypsin
remov
surfaceattach
virion
cell
subsequ
replat
fresh
medium
obtain
rate
viru
intern
inhibitor
unbound
viru
remov
time
zero
medium
contain
appropri
concentr
inhibitor
ad
time
note
fig
surfaceexpos
viru
remov
two
incub
trypsin
twentyfour
hour
later
egfp
express
cell
determin
flow
cytometri
assess
viru
entri
statist
experi
perform
triplic
statist
signific
determin
twotail
student
test
perform
largescal
bioinformat
screen
call
compar
genom
analysi
cga
screen
identifi
cellular
gene
import
ebov
gpdepend
transduct
detail
screen
approach
previous
report
screen
util
panel
human
tumor
line
panel
cell
redundantli
evalu
mrna
express
gene
array
assay
provid
mrna
express
profil
cell
line
gene
array
find
avail
public
domain
http
dtpncinihgov
permiss
cell
line
pseudotyp
nativ
glycoprotein
g
determin
incub
cell
line
equal
number
pseudovirion
result
percentag
cell
egfp
posit
correl
gene
express
data
line
compar
algorithm
gene
identifi
correl
ebov
gpor
vsvgdepend
transduct
rank
pearson
correl
coeffici
pcc
gene
within
ebov
gp
list
correl
ebov
gpand
vsvgdepend
transduct
subtract
yield
subset
gene
like
specif
involv
ebov
gpdepend
entri
rather
downstream
vsv
express
event
importantli
sever
previous
identifi
ebov
entri
factor
includ
axl
ctype
lectin
integrin
correl
strongli
ebov
transduct
screen
addit
sever
signal
molecul
previous
report
import
ebov
transductioninfect
also
identifi
screen
includ
phospholipas
c
plc
pkc
screen
success
identifi
pathway
mine
result
identifi
addit
signal
molecul
import
ebov
entri
intriguingli
subunit
ampk
correl
strongli
ebov
transduct
pcc
p
fig
ampk
recent
report
import
vv
uptak
via
macropinocytosi
macropinocytosi
import
mechan
ebov
entri
target
gene
studi
smallmolecul
inhibitor
ampk
inhibit
ebov
infect
initi
studi
ampk
requir
ebov
entri
explor
sever
cell
line
deriv
dispar
tissu
use
compound
c
also
known
dorsomorphin
membraneperm
select
inhibitor
ampk
cell
neuroblastoma
cell
line
renal
cell
line
cell
panel
express
abund
subunit
mrna
fig
central
nervou
system
cn
renal
vero
cervic
cancer
line
hela
incub
compound
c
vehicl
control
h
ebov
gppseudotyp
vsv
lfv
gpcpseudotyp
vsv
use
control
viru
throughout
studi
incub
cell
addit
h
drug
viru
remov
medium
refresh
viral
transduct
analyz
evalu
transduc
cell
egfp
express
via
flow
cytometri
h
compound
c
significantli
reduc
ebov
pseudovirion
transduct
cell
test
although
abil
concentr
block
ebov
transduct
vari
cell
line
fig
addit
inhibit
specif
ebov
gpdepend
transduct
compound
c
effect
lfv
gpcdepend
entri
viral
core
pseudovirion
stock
vsv
find
suggest
inhibitor
specif
interf
ebov
gpdepend
entri
cell
close
assess
effect
compound
c
ebov
pseudovirion
transduct
doserespons
curv
inhibitor
perform
vero
cell
studi
inhibitor
either
remov
first
incub
transduct
fig
maintain
cell
durat
experi
fig
compound
c
inhibit
ebov
pseudovirion
transduct
inhibitori
concentr
ic
regardless
whether
drug
maintain
remov
cultur
h
contrast
test
concentr
compound
c
effect
lfv
gpcdepend
entri
mainten
inhibitor
cell
durat
experi
result
greater
level
cell
cytotox
consequ
studi
use
compound
c
inhibitor
remov
follow
incub
initi
h
transduct
timeofaddit
studi
perform
understand
time
frame
compound
cdepend
inhibit
ebov
transduct
vero
cell
incub
equal
amount
ebov
pseudovirion
h
unbound
viru
remov
cell
shift
compound
c
dmso
ad
cell
min
follow
temperatur
shift
everi
hour
thereaft
h
viru
compound
c
incub
cell
total
h
replac
fresh
medium
addit
compound
c
close
initi
viral
transduct
significantli
reduc
ebov
pseudovirion
entri
fig
effect
time
sensit
compound
c
becom
ineffect
ad
h
follow
initi
transduct
implic
ampk
earli
life
cycl
event
compound
c
evalu
inhibit
replicationcompet
ebov
express
egfp
infect
fig
infect
perform
h
presenc
serial
dilut
compound
c
number
egfpexpress
cell
assess
experi
manner
similar
transduct
studi
found
inhibitor
highli
effect
block
ebov
infect
somewhat
surprisingli
inhibit
stronger
observ
transduct
studi
ic
enhanc
sensit
compound
c
infecti
viru
compar
transduc
virion
like
due
fact
vsv
replic
reduc
presenc
ampk
recent
report
inhibit
ampk
activ
may
enhanc
replic
vsv
particl
abl
enter
cell
work
provid
strong
evid
ampk
activ
import
ebov
infect
furthermor
ebov
viral
protein
present
vsv
transduct
ebov
infect
ebov
gp
studi
implic
ampk
activ
ebov
entri
event
consequ
next
determin
ebov
gpdepend
infect
human
macrophag
requir
ampk
studi
use
previous
describ
replicationcompet
recombin
vsv
ebov
gp
egfp
gene
clone
vsv
genom
place
nativ
g
glycoprotein
ebov
gprvsv
purifi
vitro
matur
human
monocytederiv
macrophag
mdm
two
donor
incub
h
dmso
compound
c
infect
ebov
gprvsv
moi
addit
h
viru
drug
remov
cell
wash
maintain
addit
h
viral
infect
analyz
egfp
express
use
fluoresc
microscopi
ebov
gprvsv
readili
infect
mdm
compound
c
significantli
reduc
ebov
gpmediat
infect
suggest
ampk
import
ebov
gpdepend
infect
primari
physiolog
relev
cell
type
fig
number
egfpexpress
cell
micrograph
quantit
voloc
imag
analysi
softwar
perkinelm
averag
cell
gfp
posit
control
popul
wherea
egfpexpress
cell
detect
compound
ctreat
well
interestingli
compound
c
treatment
alter
morpholog
mdm
produc
elong
cell
howev
compound
c
cytotox
mdm
modest
fig
cell
lack
function
ampk
less
suscept
ebov
gpmediat
infect
studi
ampk
thu
far
involv
pharmacolog
inhibitor
employ
mous
embryon
fibroblast
mef
lack
catalyt
subunit
ampk
extend
verifi
observ
ampk
cell
becom
activ
unabl
phosphoryl
downstream
target
wildtyp
wt
ampk
mef
infect
wildtyp
vsv
indiana
strain
vaccinia
viru
vv
ebov
gp
rvsv
express
egfp
report
gene
moi
viru
express
assay
h
follow
infect
fix
cell
analyz
egfp
express
use
flow
cytometri
ampk
mef
display
significantli
lower
permiss
vv
wt
mef
previous
describ
fig
interestingli
ebov
gprvsv
infect
ampk
mef
even
reduc
infect
wt
control
mef
less
wildtyp
infect
knockout
mef
reduct
ebov
gpmediat
infect
specif
glycoprotein
vsvgdepend
infect
equival
wt
ampk
mef
previous
report
find
provid
addit
evid
ampk
activ
host
cell
requir
optim
ebov
gpdepend
entri
ampk
activ
enhanc
actin
polymer
ebov
gp
dextran
uptak
incub
host
cell
vv
ebov
caus
larg
actin
protrus
increas
macropinocytosi
determin
ampk
involv
actin
polymer
presenc
ebov
pseudovirion
incub
vero
cell
vsv
particl
pseudotyp
ebov
gp
moi
equival
concentr
vsv
contain
gp
fig
gp
presenc
absenc
compound
c
incub
medium
without
drug
allow
viru
bind
synchron
entri
medium
remov
prewarm
medium
compound
c
ad
cell
min
fixat
visual
polymer
actin
stress
fiber
detect
alexa
fluor
stain
confoc
microscopi
polymer
actin
stain
zseri
captur
analyz
quantifi
voxel
number
use
imeri
imag
softwar
fig
amount
actin
polymerizationcel
appear
slightli
higher
time
zero
presenc
ebov
gp
pseudovirion
noenv
pseudovirion
although
differ
statist
signific
howev
investig
previous
found
addit
ebov
caus
signific
actin
polymer
entri
cell
min
polymer
inhibit
compound
c
reduct
actin
polymer
would
anticip
result
reduc
macropinocytosi
evalu
abil
vero
cell
treat
compound
c
wt
ampk
mef
take
highmolecularweight
dextran
cargo
commonli
use
assess
uptak
macropinocytosi
vero
cell
also
use
eipa
specif
inhibitor
plasma
membran
na
h
antiport
known
block
macropinocytosi
ebov
entri
control
found
eipa
compound
c
modestli
significantli
inhibit
fluorescein
isothiocyan
fitc
conjug
dextran
uptak
fig
similar
manner
dextran
uptak
ampk
mef
significantli
reduc
compar
wt
mef
fig
neither
experi
dextran
uptak
profoundli
inhibit
absenc
ampk
activ
ebov
infect
suggest
either
dextran
uptak
occur
cell
independ
macropinocytosi
step
ebov
infect
addit
macropinocytosi
regul
ampk
compound
c
inhibit
ebov
gp
pseudovirion
intern
dextran
uptak
reduc
absenc
ampk
function
next
sought
determin
ebov
gp
pseudovirion
intern
also
reduc
loss
ampk
activ
addit
inhibitor
use
control
studi
includ
eipa
cathepsin
b
inhibitor
allow
virion
intern
block
proteolysi
subsequ
fusion
gp
late
endosomelysosom
first
seri
experi
vero
cell
incub
effect
concentr
eipa
compound
c
dmso
control
h
addit
ebov
gp
pseudovirion
transduct
perform
presenc
inhibitor
addit
h
viru
inhibitor
remov
replac
fresh
medium
transduct
assess
h
later
expect
three
compound
inhibit
ebov
gp
pseudovirion
transduct
vero
cell
fig
second
set
experi
concentr
inhibitor
use
intern
assay
vero
cell
incub
eipa
compound
c
dmso
h
cell
chill
cell
incub
viru
addit
hour
synchron
entri
supernat
replac
prewarm
medium
contain
inhibitor
dmso
h
time
note
figur
min
min
extracellular
viru
remov
cell
surfac
two
incub
trypsin
treat
cell
replat
fresh
medium
without
inhibitor
h
cell
treat
trypsin
without
temperatur
shift
display
low
level
viru
transduct
compar
cell
viru
allow
intern
h
demonstr
trypsin
treatment
remov
surfacebound
virion
fig
h
intern
presenc
eipa
transduct
low
cell
treat
trypsin
indic
virion
remain
surfac
cell
interestingli
similar
find
observ
presenc
compound
c
demonstr
ampk
also
requir
ebov
intern
cell
surfac
expect
cathepsin
b
inhibitor
effect
intern
pseudovirion
cell
surfac
thu
second
set
condit
subsequ
transduct
inhibit
uptak
via
cellular
endocyt
machineri
allow
incom
virus
bypass
crowd
cellular
meshwork
found
cytoplasm
near
plasma
membran
deliv
viru
site
suitabl
replic
macropinocytosi
wellestablish
endocyt
mechan
uptak
larg
cargo
involv
actindepend
extens
lamellipodia
form
vesicl
macropinocyt
uptak
eukaryot
virus
rel
recent
appreci
howev
alreadi
number
genet
morpholog
dispar
virus
report
enter
cell
via
mechan
includ
filovirus
vaccinia
viru
influenza
viru
african
swine
fever
viru
found
loss
activ
key
metabol
regul
ampk
decreas
actin
polymer
reduc
ebov
dextran
uptak
ampk
identifi
potenti
import
ebov
entri
bioinformaticsbas
screen
correl
mrna
express
panel
tumor
cell
line
permiss
cell
panel
ebov
gpmediat
entri
ebov
gp
pseudovirion
transduct
ebov
infect
inhibit
absenc
ampk
activ
inhibit
specif
viral
glycoprotein
compound
c
effect
entri
vsv
pseudovirion
contain
lfv
gpc
find
implic
ampkregul
pathway
ebov
gpdepend
entri
event
ebov
entri
recent
shown
mediat
actindepend
macropinocytosi
compar
actin
polymer
presenc
absenc
compound
c
ebov
pseudovirionstimul
actin
polymer
inhibit
absenc
ampk
consist
ebov
pseudovirion
remain
surfac
cell
defect
ampk
activ
thu
propos
ampk
activ
enhanc
ebov
infect
regul
viru
uptak
cell
via
macropinocytosi
possibl
ampk
regul
addit
step
ebov
entri
express
sinc
ebov
much
effect
inhibit
loss
ampk
activ
highmolecularweight
dextran
uptak
cargo
frequent
use
assess
macropinocytosi
ampk
activ
shown
import
macropinocyt
uptak
vv
vv
report
enter
cell
stimul
actin
polymer
membran
bleb
lamellipodium
format
macropinocytosi
moser
et
al
extend
studi
demonstr
import
ampk
vv
entri
find
complement
broaden
studi
identifi
import
ampk
activ
ebov
entri
infect
well
interestingli
activ
ampk
enhanc
entri
subsequ
level
infect
envelop
virus
inhibit
replic
envelop
virus
moser
et
al
recent
show
activ
kinas
robustli
inhibit
replic
bunyaviru
rift
valley
fever
viru
reduct
lipid
level
infect
cell
studi
wildtyp
vsv
also
modestli
inhibit
ampk
activ
thu
remark
observ
profound
inhibit
ebov
gprvsv
infect
loss
ampk
activ
sinc
replic
recombin
vsv
would
expect
enhanc
reduc
activ
kinas
ampkdepend
signal
pathway
result
macropinocytosi
defin
sever
recent
studi
hint
possibl
link
ampk
activ
format
actinmedi
lamellipodium
format
macropinocytosi
protein
kinas
c
myosin
light
chain
kinas
mlck
either
previous
identifi
involv
ebov
entri
macropinocytosi
andor
identifi
cga
screen
known
phosphoryl
target
downstream
ampk
activ
vero
cell
incub
indic
inhibitor
h
cell
chill
ebov
gp
pseudovirion
allow
bind
cell
addit
hour
surfacebound
viru
either
remov
trypsin
treatment
prior
shift
temperatur
control
min
allow
transduc
h
presenc
inhibitor
dmso
control
prior
trypsin
treatment
h
cell
refresh
medium
contain
inhibitor
viral
transduct
determin
h
later
egfp
express
via
flow
cytometri
p
p
one
possibl
mean
activ
ampk
may
lead
alter
macropinocytosi
reloc
alter
function
compon
protrud
lamellipodia
ampk
activ
known
phosphoryl
anticap
protein
vasodilatorstimul
phosphoprotein
vasp
unphosphoryl
vasp
prevent
actin
cap
enhanc
actin
filament
elong
bind
barb
end
actin
wherea
actincap
protein
critic
format
lamellipodia
phosphoryl
vasp
inhibit
anticap
activ
sequestr
phosphoryl
vasp
correl
increas
cell
motil
although
vasp
regul
tip
lamellipodia
entir
clear
thu
lack
ampkdepend
vasp
phosphoryl
may
explain
decreas
motil
observ
ampk
mef
reduc
lamellipodium
format
intriguingli
phosphoryl
vasp
observ
site
ebov
entri
previous
shown
filoviru
entri
cell
vero
cell
requir
activ
wherea
ebov
entri
cell
cell
independ
activ
requir
plc
interestingli
show
ebov
transduct
highli
permiss
line
requir
ampk
suggest
either
ampk
requir
independ
pathway
ampk
activ
either
pathway
ampk
activ
downstream
pathway
moser
et
al
specul
one
rho
gtpase
may
activ
downstream
ampk
activ
shown
rho
b
c
enhanc
ebov
gpdepend
uptak
newest
find
lend
indirect
support
possibl
